De Vadder et al. reported that VIP activated intestinal gluconeogenesis [54], and Erendor at al. [58], using VIP encoded by a lentiviral gene therapy vector, suppressed diabetes-related inflammation and increased beta-cell proliferation. Here, VIP is linked to diabetes mellitus.